C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 20.5 NOK 2.5% Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Carasent ASA
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Carasent ASA
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Gross Profit
kr210.2m
CAGR 3-Years
38%
CAGR 5-Years
45%
CAGR 10-Years
2%
N
Nordhealth AS
OSE:NORDH
Gross Profit
€31.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Gross Profit
kr381.4m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
19.95 NOK
Overvaluation 3%
Intrinsic Value
Price
C

See Also

What is Carasent ASA's Gross Profit?
Gross Profit
210.2m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Gross Profit amounts to 210.2m NOK.

What is Carasent ASA's Gross Profit growth rate?
Gross Profit CAGR 10Y
2%

Over the last year, the Gross Profit growth was 14%. The average annual Gross Profit growth rates for Carasent ASA have been 38% over the past three years , 45% over the past five years , and 2% over the past ten years .

Back to Top